Groovy Medicine

Groovy Medicine was founded in 2022 and is committed to building a world-leading drug discovery platform to provide innovative drug solutions for major difficult-to-treat diseases such as cancer and neurodegenerative disorders.Groovy Medicine is dedicated to streamlining end-to-end new drug development through innovative methods and cutting-edge technologies. We have independently established a series of high-quality, high-precision, comprehensive, and proprietary databases, providing unprecedented data support for target discovery in difficult-to-treat diseases. We have developed high-dimensional biology algorithms based on modern mathematics for target discovery, identifying effective, specific, and druggable targets for complex diseases. The combination of AI-driven drug design with traditional rational optimization can significantly accelerate the new drug development process, offering novel treatment options for patients with serious refractory diseases.Currently, the company's drug discovery platform has established multiple product pipelines, and several first-in-class R&D projects have successfully advanced to the preclinical stage.